{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:31:36Z","timestamp":1776205896815,"version":"3.50.1"},"reference-count":92,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T00:00:00Z","timestamp":1255651200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1000533","type":"journal-article","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T21:53:41Z","timestamp":1255643621000},"page":"e1000533","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":207,"title":["Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy"],"prefix":"10.1371","volume":"5","author":[{"given":"Libin","family":"Rong","sequence":"first","affiliation":[]},{"given":"Alan S.","family":"Perelson","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2009,10,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0092-8674(00)81427-0","article-title":"Viral dynamics in HIV-1 infection.","volume":"93","author":"D Finzi","year":"1998","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrmicro772","article-title":"HIV-1 dynamics in vivo: implications for therapy.","volume":"1","author":"V Simon","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jtbi.2009.06.011","article-title":"Modeling HIV persistence, the latent reservoir, and viral blips.","volume":"260","author":"L Rong","year":"2009","journal-title":"J Theor Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1-infected compartments during combination therapy.","volume":"387","author":"AS Perelson","year":"1997","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.","volume":"337","author":"RM Gulick","year":"1997","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.","volume":"337","author":"SM Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.282.17.1627","article-title":"Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.","volume":"282","author":"G Dornadula","year":"1999","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1128\/JCM.41.10.4531-4536.2003","article-title":"New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.","volume":"41","author":"S Palmer","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.0800050105","article-title":"Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.","volume":"105","author":"S Palmer","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1128\/JVI.77.3.2271-2275.2003","article-title":"In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to &lt;5 copies per milliliter, with a half-life of 6 months.","volume":"77","author":"M Di Mascio","year":"2003","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/319864","article-title":"Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.","volume":"183","author":"HF Gunthard","year":"2001","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1086\/519164","article-title":"Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission.","volume":"196","author":"DM Smith","year":"2007","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.med.53.082901.104024","article-title":"The challenge of viral reservoirs in HIV-1 infection.","volume":"53","author":"JN Blankson","year":"2002","journal-title":"Annu Rev Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.280.1.67","article-title":"Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy.","volume":"280","author":"LK Schrager","year":"1998","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.","volume":"387","author":"TW Chun","year":"1997","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/nm1295-1284","article-title":"In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.","volume":"1","author":"TW Chun","year":"1995","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1084\/jem.188.1.83","article-title":"Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines.","volume":"188","author":"TW Chun","year":"1998","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.","volume":"94","author":"TW Chun","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.","volume":"278","author":"D Finzi","year":"1997","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.","volume":"278","author":"JK Wong","year":"1997","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.","volume":"5","author":"D Finzi","year":"1999","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.","volume":"9","author":"JD Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/71577","article-title":"The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.","volume":"6","author":"B Ramratnam","year":"2000","journal-title":"Nat Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1128\/JVI.77.22.12165-12172.2003","article-title":"Viral blip dynamics during highly active antiretroviral therapy.","volume":"77","author":"M Di Mascio","year":"2003","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bulm.2004.11.003","article-title":"Duration of an intermittent episode of viremia.","volume":"67","author":"M Di Mascio","year":"2005","journal-title":"Bull Math Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.293.7.817","article-title":"Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.","volume":"293","author":"RE Nettles","year":"2005","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/QAI.0b013e3180654836","article-title":"Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy.","volume":"45","author":"LE Jones","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/bulm.2001.0266","article-title":"HIV-1 infection and low steady state viral loads.","volume":"64","author":"DS Callaway","year":"2002","journal-title":"Bull Math Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"8963","DOI":"10.1128\/JVI.76.17.8963-8965.2002","article-title":"Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection.","volume":"76","author":"V Muller","year":"2002","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pcbi.0020135","article-title":"Viral and latent reservoir persistence in HIV-1-infected patients on therapy.","volume":"2","author":"H Kim","year":"2006","journal-title":"PLoS Comput Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-8-2","article-title":"Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.","volume":"8","author":"AR Sedaghat","year":"2008","journal-title":"BMC Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1371\/journal.ppat.0030122","article-title":"Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.","volume":"3","author":"AR Sedaghat","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bulm.2005.01.006","article-title":"Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART.","volume":"67","author":"LE Jones","year":"2005","journal-title":"Bull Math Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mbs.2008.10.006","article-title":"Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips.","volume":"217","author":"L Rong","year":"2009","journal-title":"Math Biosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/518250","article-title":"Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.","volume":"195","author":"TW Chun","year":"2007","journal-title":"J Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1073\/pnas.0736332100","article-title":"Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence.","volume":"100","author":"MC Strain","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1086\/428777","article-title":"Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.","volume":"191","author":"MC Strain","year":"2005","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJM199905273402101","article-title":"Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.","volume":"340","author":"L Zhang","year":"1999","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferaiton.","volume":"15","author":"N Chomont","year":"2009","journal-title":"Nat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1128\/JVI.79.15.9625-9634.2005","article-title":"Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.","volume":"79","author":"NH Tobin","year":"2005","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/90950","article-title":"Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory.","volume":"7","author":"D Homann","year":"2001","journal-title":"Nat Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nri1461","article-title":"Immune responses to Listeria monocytogenes.","volume":"4","author":"EG Pamer","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1126\/science.272.5258.54","article-title":"Immunological memory and protective immunity: understanding their relation.","volume":"272","author":"R Ahmed","year":"1996","journal-title":"Science"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1128\/JVI.75.22.10663-10669.2001","article-title":"Recruitment times, proliferation, and apoptosis rates during the CD8(+) T-cell response to lymphocytic choriomeningitis virus.","volume":"75","author":"RJ De Boer","year":"2001","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.4049\/jimmunol.171.8.3928","article-title":"Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection.","volume":"171","author":"RJ De Boer","year":"2003","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/01.qai.0000199233.69457.e4","article-title":"Density-dependent decay in HIV-1 dynamics.","volume":"41","author":"SE Holte","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development.","volume":"2","author":"SM Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.189.10.1545","article-title":"Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.","volume":"189","author":"RD Hockett","year":"1999","journal-title":"J Exp Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"19079","DOI":"10.1073\/pnas.0707449104","article-title":"Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques.","volume":"104","author":"HY Chen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0025-5564(93)90043-A","article-title":"Dynamics of HIV infection of <italic>CD<\/italic>4<sup>+<\/sup> T cells.","volume":"114","author":"AS Perelson","year":"1993","journal-title":"Math Biosci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1074-7613(00)80461-6","article-title":"The duration of antigenic stimulation determines the fate of naive and effector T cells.","volume":"8","author":"G Iezzi","year":"1998","journal-title":"Immunity"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.4049\/jimmunol.165.9.5017","article-title":"Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation.","volume":"165","author":"DM Jelley-Gibbs","year":"2000","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/87720","article-title":"Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells.","volume":"2","author":"SM Kaech","year":"2001","journal-title":"Nat Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1074-7613(00)80308-8","article-title":"Duration of TCR stimulation determines costimulatory requirement of T cells.","volume":"5","author":"TM Kundig","year":"1996","journal-title":"Immunity"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/00002030-200209270-00017","article-title":"Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy.","volume":"16","author":"G Greub","year":"2002","journal-title":"AIDS"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1172\/JCI26197","article-title":"HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.","volume":"115","author":"TW Chun","year":"2005","journal-title":"J Clin Invest"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/ni946","article-title":"Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells.","volume":"4","author":"B Seddon","year":"2003","journal-title":"Nat Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/86531","article-title":"Generation of HIV latency during thymopoiesis.","volume":"7","author":"DG Brooks","year":"2001","journal-title":"Nat Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1128\/JVI.02664-08","article-title":"Monotypic human immunodeficiency virus type 1 genotypes across the uterine cervix and in blood suggest proliferation of cells with provirus.","volume":"83","author":"ME Bull","year":"2009","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.95.20.11514","article-title":"Drug concentration heterogeneity facilitates the evolution of drug resistance.","volume":"95","author":"TB Kepler","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev.immunol.18.1.665","article-title":"Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.","volume":"18","author":"T Pierson","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/JVI.78.2.968-979.2004","article-title":"Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads.","volume":"78","author":"D Persaud","year":"2004","journal-title":"J Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/jama.286.2.196","article-title":"HIV-1 drug resistance profiles inchildren and adults with viral load of &lt;50 copies\/ml receiving combination therapy.","volume":"286","author":"M Hermankova","year":"2001","journal-title":"JAMA"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1086\/317641","article-title":"Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.","volume":"183","author":"H Imamichi","year":"2001","journal-title":"J Infect Dis"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1073\/pnas.0804192105","article-title":"HIV rebounds from latently infected cells, rather than from continuing low-level replication.","volume":"105","author":"B Joos","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00126334-200401010-00004","article-title":"Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication.","volume":"35","author":"B Ramratnam","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1073\/pnas.0903107106","article-title":"Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.","volume":"106","author":"JB Dinoso","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/dkh292","article-title":"A long-term latent reservoir for HIV-1: discovery and clinical implications.","volume":"54","author":"JD Siliciano","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1086\/382488","article-title":"Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads.","volume":"189","author":"TL Kieffer","year":"2004","journal-title":"J Infect Dis"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1128\/JVI.79.8.5185-5202.2005","article-title":"A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.","volume":"79","author":"D Monie","year":"2005","journal-title":"J Virol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"9481","DOI":"10.1128\/JVI.76.18.9481-9492.2002","article-title":"Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.","volume":"76","author":"CT Ruff","year":"2002","journal-title":"J Virol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.286.2.171","article-title":"Prevalence and predictive value of intermittent viremia with combination hiv therapy.","volume":"286","author":"DV Havlir","year":"2001","journal-title":"JAMA"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"15167","DOI":"10.1073\/pnas.96.26.15167","article-title":"Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.","volume":"96","author":"NM Ferguson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1098\/rspb.2001.1777","article-title":"The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications.","volume":"268","author":"C Fraser","year":"2001","journal-title":"Proc Biol Sci"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/315260","article-title":"Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.","volume":"181","author":"HF G\u00fcnthard","year":"2000","journal-title":"J Infect Dis"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00126334-200212010-00001","article-title":"Modeling the effects of vaccination on chronically infected HIV-positive patients.","volume":"31","author":"LE Jones","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/135965350200700404","article-title":"Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failure.","volume":"7","author":"JA Mira","year":"2002","journal-title":"Antivir Ther"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/00002030-200208160-00008","article-title":"Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients.","volume":"16","author":"JM Raboud","year":"2002","journal-title":"AIDS"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/00002030-200210180-00008","article-title":"Prevalence and clinical correlates of HIV viremia (\u2018blips\u2019) in patients with previous suppression below the limits of quantification.","volume":"16","author":"PA Sklar","year":"2002","journal-title":"AIDS"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1128\/JVI.73.11.9404-9412.1999","article-title":"Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy.","volume":"73","author":"HF G\u00fcnthard","year":"1999","journal-title":"J Virol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00126334-200110010-00001","article-title":"Transient relapses (\u201cblips\u201d) of plasma HIV RNA levels during HAART are associated with drug resistance.","volume":"28","author":"JW Cohen Stuart","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/00002030-200207260-00009","article-title":"The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to &lt;400 copies\/ml.","volume":"16","author":"PJ Easterbrook","year":"2002","journal-title":"AIDS"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jinf.2004.11.010","article-title":"Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy.","volume":"51","author":"J Macias","year":"2005","journal-title":"J Infect"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.ppat.0030046","article-title":"ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia.","volume":"3","author":"F Maldarelli","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1128\/JVI.00591-06","article-title":"Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.","volume":"80","author":"JR Bailey","year":"2006","journal-title":"J Virol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1073\/pnas.96.20.10958","article-title":"Latent reservoirs of HIV: Obstacles to the eradication of virus.","volume":"96","author":"TW Chun","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":"The challenge of finding a cure for HIV infection.","volume":"323","author":"DD Richman","year":"2009","journal-title":"Science"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00002030-199912030-00012","article-title":"Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.","volume":"13","author":"JM Prins","year":"1999","journal-title":"AIDS"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1054-3589(07)55012-X","article-title":"Treatment implications of the latent reservoir for HIV-1.","volume":"55","author":"S Peterson","year":"2007","journal-title":"Adv Pharmacol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1126\/science.279.5354.1223","article-title":"Rapid turnover of T lymphocytes in SIV-infected rhesus macaques.","volume":"279","author":"H Mohri","year":"1998","journal-title":"Science"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1128\/JVI.77.8.5037-5038.2003","article-title":"A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.","volume":"77","author":"M Markowitz","year":"2003","journal-title":"J Virol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0140-6736(99)02035-8","article-title":"Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis.","volume":"354","author":"B Ramratnam","year":"1999","journal-title":"Lancet"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T05:42:21Z","timestamp":1685166141000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000533"}},"subtitle":[],"editor":[{"given":"Rustom","family":"Antia","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2009,10,16]]},"references-count":92,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1000533","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,16]]}}}